Abstract:The National Cancer Institute's panel of 60 cancer cell lines (NCI-60) have been extensively used to screen compounds for anti-cancer activity in a wide range of molecular and pharmacologic assays. We completed a detailed analysis of the nuclear morphometric variables of 57 cancer cell lines from this drug-discovery panel using recently developed computerized method that allows simultaneously assess 42 variables related to morphology/texture of the cell nuclei. The goal of this study was to determine whether unique nuclear patterns seen in cancer cells can effectively predict response to anti-cancer therapies. Stained sections prepared from paraffin cell blocks were used to measure each cell nucleus by size (e.g. area, perimeters); by shape (e.g. area box, fractal dimensions, roundness); and by optical density of the pixels and texture (e.g. margination, heterogeneity). The obtained values were then summarized at the cell line level, generating a dataset comprising 84 variables, represented by mean values and coefficients of variation. We filtered the complete set of chemical compounds, tested on the NCI-60 panel, based on sufficient GI50 variability, narrowing the list down to 4,839 compounds. These compounds were further refined using the Benjamini-Hochberg false discovery rate (FDR) method at 1% FDR, based on the p-values from "goodness of fit" tests. This process identified 1,314 compounds where the inclusion of morphometric variables significantly improved the fit of our models. To determine which variables were highly predictive for GI50 in each compound, we performed lasso regression per compound of logged GI50 versus dummied tissue of origin and morphometric variables. We tabulated the proportion of compound models selecting each variable as well as the median relative strength for each variable. This procedure identified 10 promising compound models, in which the top 5 values of relative strength from each of the tested variables emerged. Our primary objective in this analysis was to find associations between certain nuclear morphometric parameters of tumors cells and drug sensitivity. Better defining how to use these previously untapped clues may pave the way for future studies able to predict sensitivity to cancer drugs and to help in the selection of the best anticancer treatments. Additionally, our work may draw new attention to compounds not now used for anticancer treatments, but whose increased cytotoxicity can be linked to abnormal morphometric parameters that indicate possible anti-tumor activity. Citation Format: Geula Klorin, Luz María Rodríguez, Edmond Sabo, Grant Izmirlian, Amnon Amit, Paul Meltzer, Anna Roschke. Association of nuclear morphometrical variables with drug cytotoxicity: A proof of principle using NCI-60 anti-cancer drug screening panel [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1817.

Cell morphology and gene expression: tracking changes and complementarity across time and cell lines

Applying Cell Painting in Non-Tumorigenic Breast Cells to Understand Impacts of Common Chemical Exposures

Phenotypic Profiling of Reference Chemicals across Biologically Diverse Cell Types Using the Cell Painting Assay

A Decade in a Systematic Review: The Evolution and Impact of Cell Painting

Gene Expression Patterns Within Cell Lines Are Predictive of Chemosensitivity

Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes

From Pixels to Phenotypes: Integrating Image-Based Profiling with Cell Health Data Improves Interpretability

Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals Cell Line Specific Responses and Implications for Environmental Screening

Cell Painting-based bioactivity prediction boosts high-throughput screening hit-rates and compound diversity

Optimizing the Cell Painting assay for image-based profiling

Morphological Profiling Dataset of EU-OPENSCREEN Bioactive Compounds Over Multiple Imaging Sites and Cell Lines

Unleashing the potential of cell painting assays for compound activities and hazards prediction

Cell morphological representations of genes enhance prediction of drug targets

Systematic exploration of cell morphological phenotypes associated with a transcriptomic query

Cell Painting and chemical structure read-across can complement each other for rat acute oral toxicity prediction in chemical early de-risking

Relating Chemical Structure to Cellular Response: An Integrative Analysis of Gene Expression, Bioactivity, and Structural Data Across 11,000 Compounds

Live Cell Painting: image-based profiling in live cells using Acridine Orange

Assessing the performance of the Cell Painting assay across different imaging systems

Drug-induced cytotoxicity prediction in muscle cells, an application of the Cell Painting assay

Abstract 1817: Association of nuclear morphometrical variables with drug cytotoxicity: A proof of principle using NCI-60 anti-cancer drug screening panel